Thematic Poster
Lung function practice in daily life
Chairs
J. Lloyd
Birmingham (West Midlands)
(United Kingdom)
Safety of performing Spirometry in patients with Abdominal Aortic Aneurysm (AAA )and the utility of Forced Expiratory Volume in first second (FEV1) in predicting length of postoperative hospital stay.
M. Varghese(Dublin 8, Ireland)
COI
1
Measurement of lung distensibility in healthy children
N. Gharbawi(Leicester (Leicestershire), United Kingdom)
COI
2
Bronchodilator reversibility using Impulse Oscillometry to differentiate between asthma and COPD
S. Rasam(Pune (Maharashtra), India)
COI
3
Body plethysmography abnormal parameters in 1374 individuals with normal spirometry and negative bronchodilator test
T. Jacinto(São João de Ver, Portugal)
COI
4
OROFARINGEOUS DEPOSIT OF DRUGS ADMINISTERED BY DRY POWDER INHALERS.
A. Fernandez Tena(Oviedo (Asturias), Spain)
COI
5
Aerosol characteristics of a unique breath-actuated nebulizer
R. Toddywala(Princeton, United States)
COI
6
1 Minute Sit-to-Stand Test versus 6 minutes walk test: methods of evaluating exercise capacity in COPD patients
M. Sava(Rimnicu Sarat, Romania)
COI
7
Is a cardiopulmonary exercise test (CPET) associated with an increase in high sensitivity cardiac troponin T (hs-cTnT) levels in patients with COPD?
C. Karlsen(Jessheim, Norway)
COI
8
Gastro-oesophageal reflux (GOR) during spirometry: prevalence and effects
M. Teo(Ultimo (NSW), Australia)
COI
9
Training in Multiple Breath Washout (MBW) testing for bronchiectasis (BE) clinical trials.
K. O'Neill(Belfast (Belfast), United Kingdom)
COI
10
Spirometry measured broncho-constriction in patients attending cardiac exercise tolerance test
K. Gaber(Benghazi, Libya)
COI
11
The prevalence of previously unrecognised respiratory pathology in patients attending for cardiac surgery>
S. McArthur(Edinburgh (Edinburgh), United Kingdom)
COI
12
Prevalence of COPD suitable to lung volume reduction in a hospital-based lung function outpatient clinic
C. Lalmolda Puyol(Barcelona, Spain)
COI
13
Telemedicine for quality control of spirometry in primary care. Results 6 years after implantation in a public health system.
N. Marina Malanda(Leioa (Vizcaya), Spain)
COI
14
Reference values of MostGraph (forced oscillation technique) for healthy Japanese adults
W. Furuie(Tokyo, Japan)
COI
15
Reference values of spirometry for an adult local portuguese population
S. Alberto de Carvalho(Vila Franca de Xira, Portugal)
COI
16
Comparison of the FEV1 value from five reference equations: ESCS 71|83|93, NHANES and GLI.
M. Sousa Fernandes(Lisboa, Portugal)
COI
17
. . .
